The physiological relevance of the inhibitory effects exerted by FXR ligand on breast tumor cells is pointed out by our in vivo studies showing that GW4064 administration markedly reduced growth of both MCF-7 as well as MCF-7/CAF xenografts. The gene discussed is NR1H4; the disease is breast neoplasm.